Cargando…
Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer
BACKGROUND: The satisfactory prognostic indicator of gastric cancer (GC) patients after surgery is still lacking. Perioperative plasma extracellular vesicular programmed cell death ligand-1 (ePD-L1) has been demonstrated as a potential prognosis biomarker in many types of cancers. The prognostic val...
Autores principales: | Li, Gaopeng, Wang, Guoliang, Chi, Fenqing, Jia, Yuqi, Wang, Xi, Mu, Quankai, Qin, Keru, Zhu, Xiaoxia, Pang, Jing, Xu, Baixue, Feng, Guangen, Niu, Yuhu, Gong, Tao, Zhang, Hongwei, Dong, Xiushan, Liu, Ting, Ma, Jinfeng, Gao, Zefeng, Tao, Kai, Li, Feng, Xu, Jun, Yu, Baofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986771/ https://www.ncbi.nlm.nih.gov/pubmed/33753568 http://dx.doi.org/10.1136/jitc-2020-002218 |
Ejemplares similares
-
Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression
por: Lv, Tingting, et al.
Publicado: (2022) -
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma
por: Guo, Weinan, et al.
Publicado: (2020) -
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
por: Yu, Jiongjie, et al.
Publicado: (2023) -
Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathway
por: Liu, Chang, et al.
Publicado: (2023) -
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy
por: Li, Chushu, et al.
Publicado: (2021)